Search research articles
Contact Us
Filters
Showing results (111-120 of 117) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 117 results.
Seminars in Oncology
|
August 1, 1995
Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience
C J Langer, J C Leighton, R L Comis, et al.
Cancer Research
|
July 1, 1982
A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States
R L Comis, B F Issell, K Pittman, et al.
Cancer Research
|
April 15, 1987
Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p
S L Graziano, B Y Cowan, D N Carney, et al.
Cancer Treatment Reports
|
January 1, 1985
Multicenter Phase II trial of etoposide in refractory small cell lung cancer
B F Issell, L H Einhorn, R L Comis, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 1, 1982
Phase II trial of extended indications for resection is small cell carcinoma of the lung
J A Meyer, R L Comis, S J Ginsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer
P J O'Dwyer, T C Hamilton, F P LaCreta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2009
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer
J A Treat, R Gonin, M A Socinski, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 117) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 117 results.
Seminars in Oncology
|
August 1, 1995
Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience
C J Langer, J C Leighton, R L Comis, et al.
Cancer Research
|
July 1, 1982
A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States
R L Comis, B F Issell, K Pittman, et al.
Cancer Research
|
April 15, 1987
Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p
S L Graziano, B Y Cowan, D N Carney, et al.
Cancer Treatment Reports
|
January 1, 1985
Multicenter Phase II trial of etoposide in refractory small cell lung cancer
B F Issell, L H Einhorn, R L Comis, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
January 1, 1982
Phase II trial of extended indications for resection is small cell carcinoma of the lung
J A Meyer, R L Comis, S J Ginsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer
P J O'Dwyer, T C Hamilton, F P LaCreta, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 17, 2009
A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer
J A Treat, R Gonin, M A Socinski, et al.
Page
of 12